½ÃÀ庸°í¼­
»óǰÄÚµå
1268844

¼¼°èÀÇ ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®, º¸°í¼­, ±â¼úº°(µµÇ÷¯, 3/4D), µð½ºÇ÷¹À̺°(Ä÷¯, B/W), ÃÖÁ¾ »ç¿ëÀÚº°(º´¿ø, ¿Ü·¡Áø·á¼¾ÅÍ), À¯Çüº°, ºÎ¹® µ¿Çâ (2023-2030³â)

Cardiovascular Ultrasound Market Size, Share & Trends Analysis Report By Technology (Doppler, 3/4D), By Display (Color, B/W), By End-use (Hospitals, Ambulatory Care Centers), By Type, And Segment Forecasts, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 90 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ ½ÉÇ÷°ü ÃÊÀ½ÆÄ(Cardiovascular Ultrasound) ½ÃÀå ±Ô¸ð´Â 2030³â 40¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀ̸ç, 4.96%ÀÇ CAGR ±Ô¸ð·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÉÇ÷°ü ÃÊÀ½ÆÄ °Ë»ç¸¦ ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀº »õ·Î¿î À̹Ì¡ ±â¼úÀ» ÅëÇØ ½ÉÃÊÀ½ÆÄ ÀåÄ¡ÀÇ À̹ÌÁö Á¤È®¼º°ú ÇØ»óµµ°¡ Çâ»óµÇ¾ú±â ¶§¹®ÀÔ´Ï´Ù. À̸¦ ÅëÇØ ÀÓ»óÀÇ´Â Áúº´À» È®ÀÎÇϰí Áø´ÜÇϱⰡ ½¬¿öÁ³½À´Ï´Ù. ¶ÇÇÑ ºñħ½ÀÀû Áø´Ü ¿É¼ÇÀÌ Á¦°øµÇ¹Ç·Î ħ½ÀÀû Ä¡·áº¸´Ù ¼±È£µÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù.

±âÁ¸ ¹æ¹ý¿¡ ºñÇØ ½ÉÇ÷°ü ÃÊÀ½ÆÄ °Ë»ç´Â Á¶±â ȸº¹, ÀÔ¿ø ±â°£ ´ÜÃà, ¼ö¼ú ÈÄ ÇÕº´Áõ °¨¼Ò µîÀÇ ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÁ¡Àº ³ëÀÎ Àα¸ Áõ°¡¿Í ´õºÒ¾î ½ÉÇ÷°ü ÃÊÀ½ÆÄ Áø´Ü ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

2022³â ½ÃÀå Á¡À¯À²Àº ºÏ¹Ì°¡ Ãִ븦 Â÷ÁöÇÏ¿´½À´Ï´Ù. À¯¸®ÇÑ »óȯ Ʋ°ú ¼ö¸¹Àº »ê¾÷ Ç÷¹À̾î Á¸Àç´Â ÀÌ Áö¿ª ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡¿Í Á¤±³ÇÑ °Ç°­ °ü¸® ÀÎÇÁ¶ó´Â ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ô´Ù°¡ °Ç°­ ÀÇ½Ä Áõ°¡°¡ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

COVID-19´Â CVUS¿¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù. À¯ÇàÀÇ °¡Àå µÎµå·¯Áø ¿µÇâ Áß Çϳª´Â CVUS¿Í °ü·ÃµÈ °ÍÀ» Æ÷ÇÔÇÏ´Â ¼±ÅÃÀû Ä¡·á Áö¿¬ÀÔ´Ï´Ù. ±× °á°ú ¿µ»ó Áø´Ü Àåºñ ¹× ¼­ºñ½º ¼ö¿ä°¡ °¨¼ÒÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª À¯ÇàÀÇ ¿µÇâÀ¸·Î ¿ø°Ý °¨½Ã ÀåÄ¡¿Í °¡»ó ÁøÂû µî ¿ø°Ý ÀÇ·á µµÀÔÀÌ Áõ°¡ÇÑ °Íµµ »ç½ÇÀÔ´Ï´Ù. ÀÌ ¶§¹®¿¡ ÈÞ´ë¿ë ±â±â ÀÌ¿ëÀÌ Áõ°¡ÇÏ°í ½ÃÀåÀÌ È®´ëµÇ¾ú½À´Ï´Ù.

½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ÇコÄÉ¾î ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå ±Ô¸ð´Â 2022³â 26¾ï 9,000¸¸ ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÒ Àü¸ÁÀ̸ç, 2023³â 40¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
  • ÇコÄÉ¾î ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀåÀº 2022³âºÎÅÍ 2030³â±îÁö 4.96%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© È®´ëµÇ¾úÀ¸¸ç, 2030³â 40¾ï 1,000¸¸ ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
  • 2022³â ºÏ¹Ì°¡ 29.1% ¼öÀÍ Á¡À¯À²·Î ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ÀÌ Áö¿ªÀº Áö¿ª Àüü ½ÉÇ÷°ü ÁúȯÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ ½ÃÀå È®´ë°¡ ÁøÇàµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

  • ½ÃÀå ¼¼ºÐÈ­ ¹× ¹üÀ§
    • À¯Çü
    • ±â¼ú
    • È­¸é
    • ÃÖÁ¾ ¿ëµµ
    • Áö¿ª ¹üÀ§
    • ÃßÁ¤, ¿¹Ãø ŸÀÓ¶óÀÎ
  • Á¶»ç ¹æ¹ý
  • Á¤º¸ Á¶´Þ
    • ±¸ÀÔÇÑ µ¥ÀÌÅͺ£À̽º
    • Gvr ³»ºÎ µ¥ÀÌÅͺ£À̽º
    • 2Â÷ Á¤º¸
    • 1Â÷ Á¶»ç
    • 1Â÷ Á¶»ç »ó¼¼
      • ºÏ¹Ì 1Â÷ ¸éÁ¢ µ¥ÀÌÅÍ
      • À¯·´ 1Â÷ ¸éÁ¢ µ¥ÀÌÅÍ
      • ¾Æ½Ã¾ÆÅÂÆò¾ç Áö¿ª 1Â÷ ¸éÁ¢ µ¥ÀÌÅÍ
      • ¶óƾ¾Æ¸Þ¸®Ä« 1Â÷ ¸éÁ¢ µ¥ÀÌÅÍ
      • MEA 1Â÷ ¸éÁ¢ µ¥ÀÌÅÍ
  • Á¤º¸ ¶Ç´Â µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ ºÐ¼® ¸ðÇü
  • ½ÃÀå Çü¼º°ú °ËÁõ
    • ¸ðÇü »ó¼¼
    • »óǰ Ç÷οì ÇØ¼®(¸ðÇü 1)
      • Á¢±Ù 1 : »óǰ È帧 Á¢±Ù
    • °í°¡ °¡°Ý ºÐ¼®(¸ðÇü 2)
      • Á¢±Ù 2 : °í°¡ °¡°Ý ºÐ¼®
  • 2Â÷ Á¤º¸ ¸®½ºÆ®
  • ¸ñÀû

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå ¿ªµ¿¼º
    • ½ÃÀå ÃËÁø ¿äÀÎ ºÐ¼®
      • ½ÉÇ÷°üÁúȯ À¯º´·ü Áõ°¡
      • ¿¹¹æ ÇコÄÉ¾î ³ôÀº µµÀÔÀ²
    • ½ÃÀå ¾ïÁ¦ ¿äÀÎ ºÐ¼®
      • ½ÂÀÎÀÌ ´À¸°
      • ȯºÒ Á¤Ã¥
  • ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå ºÐ¼® µµ±¸
    • ¾÷°è ºÐ¼®-Æ÷ÅÍÀÇ 5¼¼·Â
    • PESTEl ºÐ¼®

Á¦4Àå À¯Çü ºñÁî´Ï½º ºÐ¼®

  • Á¤ÀÇ¿Í ¹üÀ§
  • À¯Çü ½ÃÀå Á¡À¯À² ºÐ¼®
  • ºÎ¹® ´ë½Ãº¸µå
  • ÀÌÇÏ ½ÃÀå : ±Ô¸ð, ¿¹Ãø, °æÇ⠺м®(2016-2028³â)
  • °æÈ亮 ½ÉÃÊÀ½ÆÄ °Ë»ç
  • °æ½Äµµ ½ÉÃÊÀ½ÆÄ °Ë»ç
  • ÅÂ¾Æ ½ÉÃÊÀ½ÆÄ °Ë»ç
  • ±âŸ

Á¦5Àå ±â¼ú ºñÁî´Ï½º ºÐ¼®

  • Á¤ÀÇ¿Í ¹üÀ§
  • ±â¼ú ½ÃÀå Á¡À¯À² ºÐ¼®
  • ºÎ¹® ´ë½Ãº¸µå
  • ÀÌÇÏ ½ÃÀå : ±Ô¸ð, ¿¹Ãø, °æÇ⠺м®(2016-2028³â)
  • 2Â÷¿ø
  • 3D/4D
  • µµÇ÷¯

Á¦6Àå µð½ºÇ÷¹ÀÌ ºñÁî´Ï½º ºÐ¼®

  • Á¤ÀÇ¿Í ¹üÀ§
  • µð½ºÇ÷¹ÀÌ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ºÎ¹® ´ë½Ãº¸µå
  • ÀÌÇÏ ½ÃÀå : ±Ô¸ð, ¿¹Ãø, °æÇ⠺м®(2016-2028³â)
  • Èæ¹é
  • »ö

Á¦7Àå ÃÖÁ¾ ¿ëµµ, ºñÁî´Ï½º ºÐ¼®

  • Á¤ÀÇ¿Í ¹üÀ§
  • ÃÖÁ¾ »ç¿ëÀÚ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ºÎ¹® ´ë½Ãº¸µå
  • ÀÌÇÏ ½ÃÀå : ±Ô¸ð, ¿¹Ãø, °æÇ⠺м®(2016-2028³â)
  • º´¿ø
  • Áø´Ü ¼¾ÅÍ
  • ¿Ü·¡ Áø·á ¼¾ÅÍ
  • ±âŸ

Á¦8Àå ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå :Áö¿ª ½ÃÀå ºÐ¼®(2016-2028³â)(100¸¸ ´Þ·¯)

  • Áö¿ª ½ÃÀå Á¡À¯À² ºÐ¼®(2020-2028³â)
  • Áö¿ª ½ÃÀå ´ë½Ãº¸µå
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç Áö¿ª
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • ű¹
    • Çѱ¹
    • È£ÁÖ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿, ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ® ¿¬¹æ
    • Äí¿þÀÌÆ®

Á¦9Àå °æÀï »óȲ

  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÇÊ
    • Canon Medical Systems Corporation
      • ȸ»ç ÁÖ¿ä ¿ä¾à
      • À繫½ÇÀû
      • Á¦Ç° º¥Ä¡¸¶Å©
      • ÆÇ¸Å Àü·«
    • Ge Healthcare
      • ȸ»ç ÁÖ¿ä ¿ä¾à
      • À繫½ÇÀû
      • Á¦Ç° º¥Ä¡¸¶Å©
      • ÆÇ¸Å Àü·«
    • Koninklijke Philips NV
      • ȸ»ç ÁÖ¿ä ¿ä¾à
      • À繫½ÇÀû
      • Á¦Ç° º¥Ä¡¸¶Å©
      • ÆÇ¸Å Àü·«
    • Siemens Healthineers Ag
      • ȸ»ç ÁÖ¿ä ¿ä¾à
      • À繫½ÇÀû
      • Á¦Ç° º¥Ä¡¸¶Å©
      • ÆÇ¸Å Àü·«
    • Hitachi Healthcare Americas
      • ȸ»ç ÁÖ¿ä ¿ä¾à
      • À繫½ÇÀû
      • Á¦Ç° º¥Ä¡¸¶Å©
      • ÆÇ¸Å Àü·«
    • Samsung Medison Co., ltd.
      • ȸ»ç ÁÖ¿ä ¿ä¾à
      • À繫½ÇÀû
      • Á¦Ç° º¥Ä¡¸¶Å©
      • ÆÇ¸Å Àü·«
    • Shenzhen Mindray Bio-Medical Electronics Co., ltd.
      • ȸ»ç ÁÖ¿ä ¿ä¾à
      • Á¦Ç° º¥Ä¡¸¶Å©
      • ÆÇ¸Å Àü·«
    • Chison Wuxi Xiangsheng Medical Technology Co., ltd.
      • ȸ»ç ÁÖ¿ä ¿ä¾à
      • Á¦Ç° º¥Ä¡¸¶Å©
    • Fujifilm Sonosite, Inc.
      • ȸ»ç ÁÖ¿ä ¿ä¾à
      • Á¦Ç° º¥Ä¡¸¶Å©
      • ÆÇ¸Å Àü·«
NJH 23.05.30

Cardiovascular Ultrasound Market Growth & Trends:

The global cardiovascular ultrasound market size is expected to reach USD 4.01 billion by 2030 and expand at a CAGR of 4.96% during the forecast period, based on a new report by Grand View Research, Inc. The primary factor driving cardiovascular ultrasounds is that new imaging technologies have improved the accuracy and resolution of images obtained from echocardiography machines. This makes it easier for clinicians to identify and diagnose diseases. Additionally, it provides non-invasive diagnostic options, which are often preferred over invasive procedures.

Benefits associated with cardiovascular ultrasound over conventional methods include quick recovery, reduced span of hospitalization, and fewer post-operative complications. These benefits along with the rising geriatric population are expected to propel the demand for cardiovascular ultrasound diagnosis over the forecast period.

North America captured the largest market share in 2022. A favorable reimbursement framework and the presence of a large number of industry players are some of the major factors which can be attributed to regional growth. The rising geriatric population coupled with sophisticated healthcare infrastructure is expected to further fuel market growth in the region. Furthermore, increasing health awareness is driving demand.

COVID-19 has had a significant impact on CVUS. One of the most noticeable effects of the pandemic has been the delays in elective procedures, including those related to CVUS. As a result, which reduces the demand for imaging equipment and services. However, the pandemic has also led to an increase in telemedicine adoption, which includes the use of remote monitoring devices and virtual consultations. This led to increased use of portable devices and an expansion of the market.

Cardiovascular Ultrasound Market Report Highlights:

  • The cardiovascular ultrasound in the healthcare market size was estimated at USD 2.69 billion in 2022 and is expected to reach USD 4.01 billion in 2023
  • The global cardiovascular ultrasound in the healthcare market is expected to expand at a compound annual growth rate of 4.96% from 2022 to 2030 to reach USD 4.01 billion by 2030
  • In 2022, North America dominated the market in terms of the revenue share of 29.1%. The market's growth in the region is increasing due to an increase in cardiovascular diseases across the region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Type
    • 1.1.2 Technology
    • 1.1.3 Display
    • 1.1.4 End-Use
    • 1.1.5 Regional Scope
    • 1.1.6 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
      • 1.3.5.1 Data For Primary Interviews In North America
      • 1.3.5.3 Data For Primary Interviews In Europe
      • 1.3.5.4 Data For Primary Interviews In Apac
      • 1.3.5.6 Data For Primary Interviews In Latin America
      • 1.3.5.8 Data For Primary Interviews In Mea
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
    • 1.5.1 Model Details
    • 1.5.2 Commodity Flow Analysis (Model 1)
      • 1.5.2.1 Approach 1: Commodity Flow Approach
    • 1.5.3 Volume Price Analysis (Model 2)
      • 1.5.3.1 Approach 2: Volume Price Analysis
  • 1.6 List Of Secondary Sources
  • 1.7 Objectives
    • 1.7.1 Objective 1
    • 1.7.2 Objective 2
    • 1.7.3 Objective - 3
    • 1.7.4 Objective - 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Dynamic
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Increasing Prevalence Of Cardiovascular Diseases
      • 3.1.1.2 High Adoption Of Preventive Healthcare
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Slower Approval
      • 3.1.2.2 Reimbursement Policies
  • 3.2 Cardiovascular Ultrasound Market Analysis Tools
    • 3.2.1 Industry Analysis - Porter's
    • 3.2.2 Pestel Analysis

Chapter 4 Type Business Analysis

  • 4.1 Definitions And Scope
  • 4.2 Type Market Share Analysis
  • 4.3 Segment Dashboard
  • 4.4 Market Size & Forecasts And Trend Analyses, 2016 To 2028 For The Following
  • 4.5 Transthoracic Echocardiography
    • 4.5.1 Transthoracic Echocardiography Market Estimates And Forecast, 2016 - 2028
  • 4.6 Transesophageal Echocardiography
    • 4.6.1 Transesophageal Echocardiography Market Estimates And Forecast, 2016 - 2028
  • 4.7 Fetal Echocardiography
    • 4.7.1 Fetal Echocardiography Market Estimates And Forecast, 2016 - 2028
  • 4.8 Others
      • 4.8.1.1 Others Market Estimates And Forecast, 2016 - 2028

Chapter 5 Technology Business Analysis

  • 5.1 Definitions And Scope
  • 5.2 Technology Market Share Analysis
  • 5.3 Segment Dashboard
  • 5.4 Market Size & Forecasts And Trend Analyses, 2016 To 2028 For The Following
  • 5.5 2d
    • 5.5.1 2d Cvus Market, 2016 - 2028 (USD Million)
  • 5.6 3d/4d
    • 5.6.1 3d/4d Cvus Market, 2016 - 2028 (USD Million)
  • 5.7 Doppler
    • 5.7.1 Doppler Cvus Market, 2016 - 2028 (USD Million)

Chapter 6 Display Business Analysis

  • 6.1 Definitions And Scope
  • 6.2 Display Market Share Analysis
  • 6.3 Segment Dashboard
  • 6.4 Market Size & Forecasts And Trend Analyses, 2016 To 2028 For The Following
  • 6.5 B/W
    • 6.5.1 B/W Cvus Market, 2016 - 2028 (USD Million)
  • 6.6 Color
    • 6.6.1 Color Cvus Market, 2016 - 2028 (USD Million)

Chapter 7 End-Use Business Analysis

  • 7.1 Definitions And Scope
  • 7.2 End-Use Market Share Analysis
  • 7.3 Segment Dashboard
  • 7.4 Market Size & Forecasts And Trend Analyses, 2016 To 2028 For The Following
  • 7.5 Hospitals
    • 7.5.1 Hospitals Market, 2016 - 2028 (USD Million)
  • 7.6 Diagnostic Centers
    • 7.6.1 Diagnostic Centers Market, 2016 - 2028 (USD Million)
  • 7.7 Ambulatory Care Centers
    • 7.7.1 Ambulatory Care Centers Market, 2016 - 2028 (USD Million)
  • 7.8 Others
    • 7.8.1 Others Market, 2016 - 2028 (USD Million)

Chapter 8 Cardiovascular Ultrasound Market: Regional Market Analysis, 2016 - 2028 (USD Million)

  • 8.1 Regional Market Share Analysis, 2020 & 2028
  • 8.2 Regional Market Dashboard
  • 8.3 North America
    • 8.3.1 North America Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.3.2 U.S.
      • 8.3.2.1 U.S. Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.3.3 Canada
      • 8.3.3.1 Canada Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
  • 8.4 Europe
    • 8.4.1 Europe Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.4.2 Uk
      • 8.4.2.1 Uk Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.4.3 Germany
      • 8.4.3.1 Germany Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.4.4 France
      • 8.4.4.1 France Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.4.5 Italy
      • 8.4.5.1 Italy Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.4.6 Spain
      • 8.4.6.1 Spain Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.4.7 Denmark
      • 8.4.7.1 Denmark Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.4.8 Sweden
      • 8.4.8.1 Sweden Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.4.9 Norway
      • 8.4.9.1 Norway Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
  • 8.5 Asia Pacific
    • 8.5.1 Asia Pacific Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.5.2 Japan
      • 8.5.2.1 Japan Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.5.3 China
      • 8.5.3.1 China Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.5.4 India
      • 8.5.4.1 India Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.5.5 Thailand
      • 8.5.5.1 Thailand Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.5.6 South Korea
      • 8.5.6.1 South Korea Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.5.7 Australia
      • 8.5.7.1 Australia Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
  • 8.6 Latin America
    • 8.6.1 Latin America Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.6.2 Brazil
      • 8.6.2.1 Brazil Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.6.3 Mexico
      • 8.6.3.1 Mexico Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.6.4 Argentina
      • 8.6.4.1 Argentina Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
  • 8.7 Mea
    • 8.7.1 Mea Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.7.2 South Africa
      • 8.7.2.1 South Africa Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.7.3 Saudi Arabia
      • 8.7.3.1 Saudi Arabia Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.7.4 Uae
      • 8.7.4.1 Uae Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)
    • 8.7.5 Kuwait
      • 8.7.5.1 Kuwait Cardiovascular Ultrasound Market, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Key Company Profiles
    • 9.1.1 Canon Medical Systems Corporation
      • 9.1.1.1 Company Overview
      • 9.1.1.2 Financial Performance
      • 9.1.1.3 Product Benchmarking
      • 9.1.1.4 Strategic Initiatives
    • 9.1.2 Ge Healthcare
      • 9.1.2.1 Company Overview
      • 9.1.2.2 Financial Performance
      • 9.1.2.3 Product Benchmarking
      • 9.1.2.4 Strategic Initiatives
    • 9.1.3 Koninklijke Philips N.V.
      • 9.1.3.1 Company Overview
      • 9.1.3.2 Financial Performance
      • 9.1.3.3 Product Benchmarking
      • 9.1.3.4 Strategic Initiatives
    • 9.1.4 Siemens Healthineers Ag
      • 9.1.4.1 Company Overview
      • 9.1.4.2 Financial Performance
      • 9.1.4.3 Product Benchmarking
      • 9.1.4.4 Strategic Initiatives
    • 9.1.5 Hitachi Healthcare Americas
      • 9.1.5.1 Company Overview
      • 9.1.5.2 Financial Performance
      • 9.1.5.3 Product Benchmarking
      • 9.1.5.4 Strategic Initiatives
    • 9.1.6 Samsung Medison Co., Ltd.
      • 9.1.6.1 Company Overview
      • 9.1.6.2 Financial Performance
      • 9.1.6.3 Product Benchmarking
      • 9.1.6.4 Strategic Initiatives
    • 9.1.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 9.1.7.1 Company Overview
      • 9.1.7.2 Product Benchmarking
      • 9.1.7.3 Strategic Initiatives
    • 9.1.8 Chison Wuxi Xiangsheng Medical Technology Co., Ltd.
      • 9.1.8.1 Company Overview
      • 9.1.8.2 Product Benchmarking
    • 9.1.9 Fujifilm Sonosite, Inc.
      • 9.1.9.1 Company overview
      • 9.1.9.2 Product benchmarking
      • 9.1.9.3 Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦